Abstract
Medication nonadherence is a significant clinical problem among individuals taking statins. Poor adherence is often attributable to several reasons, yet most adherence interventions target a single reason. Baseline data were examined from a randomized clinical trial of 236 patients with hyperlipidemia. A latent class analysis was then performed on patients reporting any nonadherence (n = 109). A 4-class solution provided the most optimal fit and differentiation of classes. Class 1 (N = 59, 54%) included patients who reported occasionally forgetting. Class 2 (N = 16, 14%) represented patients who were concerned about side effects. Class 3 (N = 17, 16%) represented patients who reported out-of-routine life events as contributing to nonadherence. Class 4 (N = 17, 16%) represented patients who endorsed a large number reasons indiscriminately. Class membership was almost uniformly unrelated to any patient demographic factors or treatment arm. Each cluster of reasons defining these patients may be best addressed through different intervention strategies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AlGhurair, S. A., Hughes, C. A., Simpson, S. H., & Guirguis, L. M. (2012). A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the World Health Organization Multidimensional Adherence Model. The Journal of Clinical Hypertension, 14, 877–886.
Blalock, D. B., Zullig, L. L., Bosworth, H. B., Taylor, S., & Voils, C. I. (under review). Self-reported medication nonadherence predicts cholesterol levels, and demonstrates causal priority over time.
Bosworth, H. B., Blalock, D. V., Hoyle, R. H., Czajkowski, S., & Voils, C. I. (in press). The role of psychological science in efforts to improve cardiovascular medication adherence. American Psychologist.
Bosworth, H. B., Olsen, M. K., McCant, F., Stechuchak, K. M., Danus, S., Crowley, M. J., et al. (2018). Telemedicine cardiovascular risk reduction in veterans: The CITIES trial. American Heart Journal, 199, 122–129.
Brown, I., Sheeran, P., & Reuber, M. (2009). Enhancing antiepileptic drug adherence: A randomized controlled trial. Epilepsy & Behavior, 16, 634–639.
Choudhry, N. K., Krumme, A. A., Ercole, P. M., Girdish, C., Tong, A. Y., Khan, N. F., et al. (2017). Effect of reminder devices on medication adherence: The REMIND randomized clinical trial. JAMA Internal Medicine, 177, 624–631.
Eisenberg, D. A. (1998). Cholesterol lowering in the management of coronary artery disease: The clinical implications of recent trials. The American Journal of Medicine, 104, 2S–5S.
Gadkari, A. S., & McHorney, C. A. (2012). Unintentional non-adherence to chronic prescription medications: How unintentional is it really? BMC Health Services Research, 12, 98–109.
Gellad, W. F., Thorpe, C. T., Steiner, J. F., & Voils, C. I. (2017). The myths of medication adherence. Pharmacoepidemiology and Drug Safety, 26, 1437–1441.
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: Its importance in cardiovascular outcomes. Circulation, 119, 3028–3035.
Ho, P. M., Lambert-Kerzner, A., Carey, E. P., Fahdi, I. E., Bryson, C. L., Melnyk, S. D., et al. (2014). Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: A randomized clinical trial. JAMA Internal Medicine, 174, 186–193.
Jerant, A., DiMatteo, R., Arnsten, J., Moore-Hill, M., & Franks, P. (2008). Self-report adherence measures in chronic illness: Retest reliability and predictive validity. Medical Care, 46, 1134–1139.
Kardas, P., Lewek, P., & Matyjaszczyk, M. (2013). Determinants of patient adherence: A review of systematic reviews. Frontiers in Pharmacology, 4, 91.
Liberopoulos, E. N., Florentin, M., Mikhailidis, D. P., & Elisaf, M. S. (2008). Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opinion on Drug Safety, 7, 717–725.
Linzer, D. A., & Lewis, J. B. (2011). poLCA: An R package for polytomous variable latent class analysis. Journal of Statistical Software, 42, 1–29.
Magidson, J., & Vermunt, J. (2002). Latent class models for clustering: A comparison with K-means. Canadian Journal of Marketing Research, 20, 36–43.
Melnyk, S. D., Zullig, L. L., McCant, F., Danus, S., Oddone, E., Bastian, L., et al. (2013). Telemedicine cardiovascular risk reduction in veterans. American Heart Journal, 165, 501–508.
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., et al. (2014). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD000011.pub4.
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497.
Sabaté, E. (Ed.). (2003). Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization.
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 43, 521–530.
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Merz, C. N. B., Blum, C. B., Eckel, R. H., et al. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 63(25 Part B), 2889–2934.
van Driel, M. L., Morledge, M. D., Ulep, R., Shaffer, J. P., Davies, P., & Deichmann, R. (2016). Interventions to improve adherence to lipid-lowering medication. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD004371.pub4.
Voils, C. I., King, H. A., Neelon, B., Hoyle, R. H., Reeve, B. B., Maciejewski, M. L., et al. (2014). Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions. Patient Preference and Adherence, 8, 643–650.
Voils, C. I., Maciejewski, M. L., Hoyle, R. H., Reeve, B. B., Gallagher, P., Bryson, C. L., et al. (2012). Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Medical Care, 50, 1013–1019.
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., et al. (2012). A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology, 73, 691–705.
Yang, C. C. (2006). Evaluating latent class analysis models in qualitative phenotype identification. Computational Statistics & Data Analysis, 50, 1090–1104.
Zhou, X. H., McClish, D. K., & Obuchowski, N. A. (2009). Statistical methods in diagnostic medicine (Vol. 569). Hoboken: Wiley.
Funding
Dr. Blalock was supported by Grant No. TPH 21-000 from the Department of Veterans Affairs Office of Academic Affiliations. Drs. Bosworth and Voils are supported by VA HSR&D Research Career Scientist (RCS) Awards (RCS 08-027 and RCS 14-443, respectively). The study was funded by a VA HSRD grant to Dr. Bosworth (IIR 08-297). This work was also supported by the Center of Innovation for Health Services Research in Primary Care (CIN 13-410) at the Durham VA Medical Center. We thank Felicia McCant, MSW and Susanne Danus, BS for their administrative support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dan V. Blalock, Hayden B. Bosworth, Bryce B. Reeve and Corrine I. Voils declare that they have no conflict of interest.
Human and animal rights and Informed consent
All procedures followed were in accordance with ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Blalock, D.V., Bosworth, H.B., Reeve, B.B. et al. Co-occurring reasons for medication nonadherence within subgroups of patients with hyperlipidemia. J Behav Med 42, 291–299 (2019). https://doi.org/10.1007/s10865-018-9954-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10865-018-9954-3